pancreatic cysts
Interpace Diagnostics to Cease PancraGen Testing After Losing CMS Reimbursement
The fate of its pancreatic cancer test had been in limbo for years, but with a newly active LCD from Medicare contractor Novitas, the firm has had to close the book on the assay.
Biological Dynamics, OHSU Partner to Validate Pancreatic Cancer Early Detection Test
The collaboration will involve testing 520 samples from pancreatic cancer patients and healthy individuals using the exosome-isolating ExoVita Pancreas assay.
Interpace, Rutgers, Mass General Sign Deal for Pancreatic Cyst Risk Assessment Biomarker
Interpace said that the novel monoclonal antibody, Das-1, will provide additional data regarding pancreatic cancer risk to guide personalized patient management.